Bellerophon Therapeutics
| Region | Nordamerika |
| ISIN | US0787713009 |
| Sektor | Medizintechnik, Biotech |
| Website | https://bellerophon.com/ |
Bellerophon is a clinical-stage biotherapeutics company focused on developing innovative therapies that address significant unmet medical needs in the treatment of cardiopulmonary diseases.
| Titel | Autor | Datum |
|---|---|---|
|
NO to COVID!
|
rotten.tom | vor ungefähr 3 Monaten |
| Titel | Datum |
|---|---|
| Bellerophon launches late-stage study of INOpulse in lung-scarring diseases | vor ungefähr 3 Monaten |
| Bellerophon Therapeutics, Inc. - 8-K, Current Report | vor ungefähr 3 Monaten |
| Bellerophon Therapeutics, Inc.: Bellerophon Therapeutics Announces First Patient Enrolled in Phase 3 REBUILD Study Evaluating INOpulse fo... | vor ungefähr 3 Monaten |
| Mid-Afternoon Market Update: Dow Surges 250 Points; Bellerophon Therapeutics Shares Slide | vor ungefähr 3 Monaten |
| Medigus, 180 Life Sciences leads healthcare gainers; Bellerophon Therapeutics, BioLineRx among major losers | vor ungefähr 3 Monaten |
| Diese Aktien könnten Dich auch interessieren | |
|---|---|
| Bee Vectoring Technologies (1 Artikel) | |
| Bayer (1 Artikel) | |
| Benz Mining (1 Artikel) | |
| Berkeley Energia (1 Artikel) | |
| Alle anzeigen | |